Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. It blocks viral entry into host cells while preserving normal immunologic function. The Company is also investigating an intramuscular method of administration of Trogarzo. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy.

TSX:TH - Post by User

Theratechnologies Inc > Are the executives and the board that dumb and unware?

<< Previous

Bullboard Posts

Next >>

Comment by houbahopon Mar 28, 2023 8:21pm

63 Views

Post# 35365829

RE:RE:RE:Are the executives and the board that dumb and unware?

They should have given more shares to Marathon and treat themselves with more options, just to
make sure " you know they throw it in your face".

The last shoe to drop will be when they announce declining sales.

Only after then, new money might come in.

<< Previous

Bullboard Posts

Next >>

High Tide adds two stores to undervalued cannabis retail network